Yeaman Kevin J's Form 4 filing
Dolby Laboratories, Inc. (DLB) · filed Jan 12, 2022
- Accession no.
- 0001209191-22-003133
- Filed
- Jan 12, 2022
- Trade date
- Jan 11, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.22M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yeaman Kevin JCIK 0001200469 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 11, 2022 | Class A Common Stock | SSaleDisposed | −5,168 | $93.11F1 | −$481,192.48 | 21,741 | Indirect | |
| Jan 11, 2022 | Class A Common Stock | MOption exerciseAcquired | +29,453 | $42.98 | +$1,265,889.94 | 51,194 | Indirect | |
| Jan 11, 2022 | Class A Common Stock | SSaleDisposed | −29,453 | $93.10F2 | −$2,742,074.3 | 21,741 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 11, 2022 | Class A Common Stock | MOption exerciseDisposed | −29,453 | $0.00 | $0 | 188,504 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $92.65 to $93.53, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $92.65 to $93.53, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
Remarks
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.